TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Speed of sound (SOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma caffeine PK profile of (AUC0-t, AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma caffeine PK profile of peak caffeine concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 5 times sit to stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cognitive Function Composite Score at 12 Months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Fluid Cognition Composite Score at 12 Months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Crystallized Cognition Composite Score at 12 Months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in intelligence using the Kaufman Brief Intelligence Scale (KBIT-2)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in attention using the Wechsler Intelligence Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in processing speed using the Cambridge Neuropsychological Test Automated Battery (CANTAB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of life assessed by KCCQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Distance in meters at 6-min walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal Risk Screening Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative number of hospitalisations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Presence or absence of new bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Treatment-related moderate-severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical activity of larotrectinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capillary blood glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Threshold cycle value of SARS-CoV-2 by PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 Nucleocapsid protein in saliva by ELISA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with platelet count ≥ 30 × 10^9/L and 50×10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Achieving the Target Heart Rate Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fertility Quality of Life Questionnaire (FertiQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Theory of Mind scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Theory of Mind Inventory-2 (ToMI-2-C)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Theory of Mind Task Battery (ToMTB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual perspective taking
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in VAS score regarding importance of UV-protection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in VAS score regarding rating of personal exposure to UV radiation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in MADRS Total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of Acute cellular rejection (ACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ankylosing Spondylitis Disease Activity Score-C Reactive Protein (ASDAS-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical rating scale of pain (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 2+ cardiotoxicity events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in volume of urine in millilitre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in intensity and frequency of urine leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in urine incontinence on Stamey's incontinence scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: RCB index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in patient reported GI and GU quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from the baseline swallowing function at 8-weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the forward head position at 8-weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence of CAR-T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormally clinical vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal clinically significant 12-lead electrocardiogram (ECG) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Invasive vascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Non-invasive vascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maximal power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slope of F-V profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Health Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of oesophagus compressible
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma Concentration of delta-9 tetrahydrocannabinol (THC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of MRI inflammatory of the sacroiliac joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Success of Regional Anesthesia for Impella 5.5 Placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of complications within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with a diagnosis of PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent to which participants have been bothered by PTSD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of depression as assessed by QIDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of attitudes, behaviors and plans to commit suicide
Endpoint domain: Adverse events/effects
Primary endpoint: Measure of suicidal ideation and behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with anxiety, mood, psychotic, substance, and eating disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular surface health evaluate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic biomarker for early breast cancer (EBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change efficacy (Pain free at two hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indicators of physical and psychological wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Size of granulation tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum Residual Disease (MRD) Negative Remission Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positional Deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With ≥1 Solicited Injection-site Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With ≥1 Solicited Systemic Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With ≥1 Vaccine-related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Time of passage of flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Neurological events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduced Pain Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 minute sit to stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocabulary gains
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Body Dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaphragm and Sternocleidomastoid muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in symptoms of individual stress level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Insulin resistance index at fasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transcutaneous bilirubin levels from covered skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcutaneous bilirubin levels from open skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic factors of severe mediastinal mass syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD Checklist-5 (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease Activity Score for 28 joints (DAS28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Respiratory Tract Infection (RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of Gaucher disease (GD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of acid sphingomyelinase deficiency (ASMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ABILHAND-KIDS tool scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative visual analog scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Rate of heart beat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Value of systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of systemic inflammation index (SII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of AKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in MSC-derived cancer support factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck shaft angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability and feasibility of hrHPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability and feasibility of teaching SMM in Tanzania to conduct self-exams
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Screening practices of hrHPV-related OPCa
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hypotension more than 25% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of human allogenic BM derived MSCs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of bacterial catheter infections
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Midline diastema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dementia Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: General Self Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 2 Minute Walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detect myocardial perfusion defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evaluate the image quality of GE-267
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory Therapist Likert Scale Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Standard of care invasive electroanatomical mapping system duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VIVO non-invasive mapping system duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical status on the WHO-8-Category ordinal scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Subjects With Minimal Residual Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patients completing induction chemotherapy cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior thigh muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lower Extremity Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of patients with CPE carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Minnesota Manual Dexterity Test (MMDT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence, frequency, and severity of Treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Passive straight leg raise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Passive ankle dorsiflexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD8+ T-cell tumor infiltration density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Arm swing amplitude-shoulder degrees in flexion-extension direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arm swing amplitude-elbow degrees in flexion-extension direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arm swing amplitude-overall degrees in flexion-extension direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step-speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two Minute Walk Test (2MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Montreal Cognitive Assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Trail Making Test Part A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Trail Making Test Part B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Digit Span test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in MoCA-Memory Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic accuracy of D-OCT in diagnosing BCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival motor neuron (SMN) circular RNA
Endpoint domain: Mortality/survival
Primary endpoint: multidrug-resistant organisms bacteremia
Endpoint domain: Adverse events/effects
Primary endpoint: Nail psoriasis index (NAPSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Posttraumatic Stress Disorder Scale (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recovery of wall prosthesis infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Observed serum concentration (Ctrough)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with injection site reactions and immune-mediated reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Cosmetic Outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of subjects reporting Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects reporting Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of thrombotic events
Endpoint domain: Adverse events/effects
Primary endpoint: Fasting glucose measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: World Health Organization Quality of life Short Form
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Depressive symptoms at 24 Months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Depressive symptoms at intermediate timepoints
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 24 Month Relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Strength and Difficulties Questionnaire (SDQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: First Occurrence of RT-PCR-Confirmed RSV Mediated LRTD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: UPDRS III score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Levodopa equivalent daily dosage changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24-hour average ambulatory blood pressure monitoring systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Artificial Intelligence software performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with CRBSI
Endpoint domain: Adverse events/effects
Primary endpoint: General Anxiety Disorder (GAD7) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Insomnia severity Index (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Hemogram indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lipid trafficking score LT-Mo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of dysmenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percent (%) positive deep tissue infections
Endpoint domain: Adverse events/effects
Primary endpoint: Percent (%) negative deep tissue infections
Endpoint domain: Adverse events/effects
Primary endpoint: Disease Free Survival (DFS) Rate at 24 Months
Endpoint domain: Mortality/survival
Primary endpoint: Jaeger near uncorrected visual acuity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hospitalization episodes
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change From Baseline in KCCQ-CSS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Early detection of non-small cell lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Anterior wall descensus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of spontaneous voiding of bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Recurrence of glioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 90-day surgical site infection incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in emotion regulation abilities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adverse events (AE) and serious adverse events (SAE) occurrence and frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical reasoning assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in postprandial glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Area under the plasma glucose curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes